Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Paul, Thevenot"'
Autor:
Kelley Núñez, Michael Schneider, Tyler Sandow, Juan Gimenez, Mina Hibino, Daniel Fort, Ari Cohen, Paul Thevenot
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 3, Pp 316-325 (2024)
Background and Aims: Assessing aggressive biology at early-stage hepatocellular carcinoma (HCC) diagnosis remains challenging. Alpha-fetoprotein (AFP) is the only clinical biomarker of aggressive HCC. In this study, AFP, Lens culinaris agglutinin-rea
Externí odkaz:
https://doaj.org/article/73dde3b192c541318bdd0fe06f2f0ea5
Autor:
Oscar Gomez-Torres, Shripa Amatya, Lilly Kamberov, Hemangini A. Dhaibar, Pranshu Khanna, Oren Rom, Arif Yurdagul, A. Wayne Orr, Kelly Nunez, Paul Thevenot, Ari Cohen, Hrishikesh Samant, Jonathan S. Alexander, Emma Burgos-Ramos, Adrian Chapa-Rodriguez, Diana Cruz-Topete
Publikováno v:
American journal of physiology. Gastrointestinal and liver physiology. 323(3)
Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent forms of chronic liver disease in the United States and worldwide. Nonalcoholic steatohepatitis (NASH), the most advanced form of NAFLD, is characterized by hepatic steatosis assoc
Autor:
Tyler Sandow, Juan Gimenez, Kelley Nunez, Richard Tramel, Patrick Gilbert, Brianna Oliver, Michael Cline, Kirk Fowers, Ari Cohen, Paul Thevenot
Purpose To evaluate sphere concentration delivered to tumor and non-tumor tissue using voxel-based dosimetry as it relates to treatment, pathologic outcomes, and adverse events.Methods A retrospective, single-center analysis of patients (n = 57) with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2978c58d15cb413ef17c27eb86d6ae23
https://doi.org/10.21203/rs.3.rs-2790650/v1
https://doi.org/10.21203/rs.3.rs-2790650/v1
Autor:
Paulo C. Rodriguez, Luis Del Valle, Jimena Trillo-Tinoco, Augusto C. Ochoa, Chris Parsons, Yan Cui, Patrick L. Raber, Paul Thevenot, Rosa A. Sierra
An impaired antitumor immunity is found in patients with cancer and represents a major obstacle in the successful development of different forms of immunotherapy. Signaling through Notch receptors regulates the differentiation and function of many ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0fd0755cdf947dbc3cf28a6077e72a9
https://doi.org/10.1158/2326-6066.c.6548341.v1
https://doi.org/10.1158/2326-6066.c.6548341.v1
Autor:
Paulo C. Rodriguez, Luis Del Valle, Jimena Trillo-Tinoco, Augusto C. Ochoa, Chris Parsons, Yan Cui, Patrick L. Raber, Paul Thevenot, Rosa A. Sierra
PDF file - 97KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f38c755bd52ca60fafa0ef9035314c9
https://doi.org/10.1158/2326-6066.22537186.v1
https://doi.org/10.1158/2326-6066.22537186.v1
Autor:
Paulo C. Rodriguez, Augusto C. Ochoa, Dorota D. Wyczechowska, Claudia Hernandez, Dulfary Sanchez-Pino, Amir A. Al-Khami, Paul Thevenot, Patrick Raber, Rosa A. Sierra, Maria E. Ramirez, Matthew Fletcher
Supplemental Methods and legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20baead3b7382bae344ebf7afc51da44
https://doi.org/10.1158/0008-5472.22407836
https://doi.org/10.1158/0008-5472.22407836
Autor:
Paulo C. Rodriguez, Augusto C. Ochoa, Dorota D. Wyczechowska, Claudia Hernandez, Dulfary Sanchez-Pino, Amir A. Al-Khami, Paul Thevenot, Patrick Raber, Rosa A. Sierra, Maria E. Ramirez, Matthew Fletcher
Supplemental Figure 1. Peg-Arg I blocks T cell proliferation and IFNy production. Supplemental Figure 2. Peg-Arg I does not alter T cell percentages in naive mice. Supplemental Figure 3. Effects of peg-Arg I on T-cell glycolysis. Supplemental Figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::943db767fe7aea3705d0b57757b7b15e
https://doi.org/10.1158/0008-5472.22407839.v1
https://doi.org/10.1158/0008-5472.22407839.v1
Autor:
Valerie Zabala, Joan M Boylan, Paul Thevenot, Anderson Frank, Dewahar Senthoor, Varun Iyengar, Hannah Kim, Ari Cohen, Philip A Gruppuso, Jennifer A Sanders
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0227038 (2019)
There are few effective targeted strategies to reduce hepatic ischemia-reperfusion (IR) injury, a contributor to poor outcomes in liver transplantation recipients. It has been proposed that IR injury is driven by the generation of reactive oxygen spe
Externí odkaz:
https://doaj.org/article/12b5b00b6c6e468d98366405ff82160d
Autor:
Ali Riza, Koksal, Paul, Thevenot, Yucel, Aydin, Kelley, Nunez, Tyler, Sandow, Kyle, Widmer, Leela, Nayak, John, Scott, Molly, Delk, Martin W, Moehlen, Ari J, Cohen, Srikanta, Dash
Publikováno v:
Journal of Hepatocellular Carcinoma.
Ali Riza Koksal,1,2 Paul Thevenot,3 Yucel Aydin,1 Kelley Nunez,3 Tyler Sandow,4 Kyle Widmer,5 Leela Nayak,5 John Scott,1 Molly Delk,2 Martin W Moehlen,2 Ari J Cohen,3,6 Srikanta Dash1,2,5 1Department of Pathology and Laboratory Medicine, Tulane Unive
Autor:
Jonathan S Alexander, Emma Burgos-Ramos, Adrian Chapa-Rodriguez, Ari Cohen, Diana Cruz-Topete, Hemangini Dhaibar, Oscar Gomez-Torres, Lilly Kamberov, Pranshu Khanna, Kelly Nunez, Wayne A Orr, Orem Ron, Hrishikesh Samant, Paul Thevenot, Arif Yurgadul, Shripa Amatya
Publikováno v:
Journal of the Endocrine Society. 6:A247-A248
The signaling lymphocytic activation molecule 1 (SLAMF1) exerts a role in regulating the immune response to some viruses and parasite infections. In the present study, we identified SLAMF1 as a potential therapeutic target and biomarker for Non-Alcoh